- Home
- INTA vs XENE Comparison
INTA vs XENE Comparison
Compare INTA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTA | XENE |
|---|---|---|
| Founded | 2000 | 1996 |
| Country | United States | Canada |
| Employees | N/A | 327 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | INTA | XENE |
|---|---|---|
| Price | $38.69 | $42.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $60.00 | $54.09 |
| AVG Volume (30 Days) | 461.9K | ★ 1.0M |
| Earning Date | 02-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $524,342,000.00 | $7,500,000.00 |
| Revenue This Year | $15.67 | N/A |
| Revenue Next Year | $13.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.11 | N/A |
| 52 Week Low | $35.51 | $26.74 |
| 52 Week High | $77.74 | $46.60 |
Technical Indicators
Market Signals| Indicator | INTA | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 50.44 |
| Support Level | $36.98 | $39.29 |
| Resistance Level | $45.73 | $42.00 |
| Average True Range (ATR) | 1.70 | 2.01 |
| MACD | -0.80 | -0.08 |
| Stochastic Oscillator | 18.79 | 50.63 |
Price Performance
Historical ComparisonAbout INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.